Open access

Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis
Joanna Shim, Gareth T Jones, Ejaz M I Pathan, Gary J Macfarlane

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-213590; DOI: 10.1136/annrheumdis-2018-213590
Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
Azita Sohrabian, Linda Mathsson-Alm, Monika Hansson, Ann Knight, Jörgen Lysholm, Martin Cornillet, Karl Skriner, Guy Serre, Anders Larsson, Tomas Weitoft, Johan Rönnelid

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1345-1353; DOI: 10.1136/annrheumdis-2017-212627
Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ
Xiaodi Tang, Hayat Muhammad, Celia McLean, Jadwiga Miotla-Zarebska, Jacob Fleming, Athanasios Didangelos, Patrik Önnerfjord, Andrew Leask, Jeremy Saklatvala, Tonia L Vincent

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1372-1380; DOI: 10.1136/annrheumdis-2018-212964
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
Christopher P Denton, Voon H Ong, Shiwen Xu, Haiyin Chen-Harris, Zora Modrusan, Robert Lafyatis, Dinesh Khanna, Angelika Jahreis, Jeffrey Siegel, Thierry Sornasse

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1362-1371; DOI: 10.1136/annrheumdis-2018-213031
CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease
Mitsuhiro Akiyama, Hidekata Yasuoka, Keiko Yoshimoto, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1386-1387; DOI: 10.1136/annrheumdis-2017-212110
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan Solinger, Yakov Datsenko, Chandrasena Pamulapati, Sudha Visvanathan, David B Hall, Stella Aslanyan, Paul Scholl, Steven J Padula

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1295-1302; DOI: 10.1136/annrheumdis-2018-213328
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)
Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, Masayuki Inoo, Hitomi Kobayashi-Haraoka, Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekara Yasuoka, Shintaro Hirata, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi

Annals of the Rheumatic Diseases Sep 2018, 77 (9) 1268-1275; DOI: 10.1136/annrheumdis-2018-213416
Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
Josef S Smolen, Ronald F van Vollenhoven, Stefan Florentinus, Su Chen, Jessica L Suboticki, Arthur Kavanaugh

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-213502; DOI: 10.1136/annrheumdis-2018-213502
Comparing image analysis approaches versus expert readers: the relation of knee radiograph features to knee pain
Luca Minciullo, Matthew J Parkes, David T Felson, Timothy F Cootes

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-213492; DOI: 10.1136/annrheumdis-2018-213492
Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
Mascha Koenen, Stephan Culemann, Sabine Vettorazzi, Giorgio Caratti, Lucien Frappart, Wolfgang Baum, Gerhard Krönke, Ulrike Baschant, Jan P Tuckermann

Annals of the Rheumatic Diseases Jul 2018, annrheumdis-2017-212762; DOI: 10.1136/annrheumdis-2017-212762

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages